請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60803
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳明汝(Ming-Ju chen) | |
dc.contributor.author | Chun-Yi Lai | en |
dc.contributor.author | 賴君宜 | zh_TW |
dc.date.accessioned | 2021-06-16T10:30:53Z | - |
dc.date.available | 2014-08-16 | |
dc.date.copyright | 2013-08-16 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-14 | |
dc.identifier.citation | 王聖耀。2011。探討克弗爾粒與viili菌元之菌群分布並研究其分離菌株之生物膜形成機制。國立臺灣大學生物資源暨農學院動物科學技術學系。博士論文。
劉嚞睿。2001。克弗爾特性與機能活性之研究。國立臺灣大學生物資源暨農學院動物科學技術學系。博士論文。 謝馨慧。2011。糖液克弗爾粒於不同發酵基質中之菌相分布與其分離菌株抗腸炎機能性之研究。國立臺灣大學生物資源暨農學院動物科學技術學系。碩士論文。 Adebayo-tayo, B. C. and A. A. Onilude. 2008. Screening of lactic acid bacteria strains isolated from some Nigerian fermented foods for EPS production. World Applied Sciences Journal. 4: 741-747. Ahrne, S., S. Nobaek, B. Jeppsson, I. Adlerberth, A. Wold and G. Molin. 1998. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85: 88-94. Alp, G. and B. Aslim. 2010. Relationship between the resistance to bile salts and low pH with exopolysaccharide(EPS)production of Bifidobacterium spp. Isolated from infants feces and breast milk. Anaerobe. 16: 101-105. Assadi, M., R. Pourahmad and N. Moazami. 2000. Use of isolated kefir starter cultures in kefir production. World J. Microb. Biot.16: 541-543. Ataie-Jafari, A., B. Larijani and F. Tahbaz. 2009. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab. 54: 22-27. Begley, M., C. Hill and C. G. Gahan. 2006. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72: 1729-1738. Bhatnagar, D., H. Soran and P. N. Durrington. 2008. Hypercholesterolaemia and its management. BMJ. 337. Cheirsilp, B., H. Shimizu and S. Shioya. 2003. Enhanced kefiran production by mixed culture of Lactobacillus kefiranofaciens and Saccharomyces cerevisiae. J. Biotechnol. 100: 43-53. Chen, H. C., S. Y. Wang and M. J. Chen. 2008. Microbiological study of lactic acid bacteria in kefir grains by culture-dependent and culture-independent methods. Food Microbiol. 25: 492-501. Chen, M. J., J. R. Liu, J. F. Sheu, C. W. Lin and C. L. Chuang. 2006. Study on skin care properties of milk kefir whey. AJAS. 19: 905. Chen, T. H., S. Y. Wang, K. N. Chen, J. R. Liu and M. J. Chen. 2009. Microbiological and chemical properties of kefir manufactured by entrapped microorganisms isolated from kefir grains. J. Dairy Sci. 92: 3002-3013. Chen, Y. P., P. J. Hsiao, W. S. Hong, T. Y. Dai and M. J. Chen. 2012. Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo. J. Dairy Sci. 95: 63-74. Chiang, Y. R., W. Ismail, D. Heintz, C. Schaeffer, A. Van Dorsselaer and G. Fuchs. 2008. Study of anoxic and oxic cholesterol metabolism by Sterolibacterium denitrificans. J. Bacteriol. 190: 905-914. Chikai, T., H. Nakao and K. Uchida. 1987. Deconjugation of bile acids by human intestinal bacteria implanted in germ-free rats. Lipids. 22: 669-671. Corzo, G. and S. Gilliland. 1999. Bile salt hydrolase activity of three strains of Lactobacillus acidophilus. J. Dairy Sci. 82: 472-480. Dadkhah, S., R. Pourahmad, M. M. Assadi and A. Moghimi. 2011. Kefir production from soymilk. Ann. Biol. Res. 2: 293-299. De Roos, N., G. Schouten and M. Katan. 1999. Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur. J. Clin. Nutr. 53: 277. De Smet, I., P. De Boever and W. Verstraete. 1998. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Brit. J. Nutr. 79: 185-194. de Vries, M. C., E. E. Vaughan, M. Kleerebezem and W. M. de Vos. 2006. Lactobacillus plantarum-survival, functional and potential probiotic properties in the human intestinal tract. Int. Dairy. J. 16: 1018-1028. Dubois, M., K. A. Gilles, J. K. Hamilton, P. A. Rebers and F. Smith. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28: 350-356. Garrote, G. L., A. G. Abraham and G. L. de Antoni. 1998. Characteristics of kefir prepared with different grain: milk ratios. J. Dairy Res. 65: 149-154. Garrote, G. L., A. G. Abraham and G. L. de Antoni. 2001. Chemical and microbiological characterisation of kefir grains. J. Dairy Res. 68: 639-652. Ghoshal, U. C., V. Sengar and D. Srivastava. 2012. Colonic transit study technique and interpretation: Can these be uniform globally in different populations with non-uniform colon transit time? J. Neurogastroent. Motil. 18: 227-228. Gill, H. S. and F. Guarner. 2004. Probiotics and human health: A clinical perspective. Postgrad. Med. J. 80: 516-526. Groenewald, W. H., C. A. van Reenen and L. M. T. Dicks. 2006. Strains of Lactobacillus plantarum in grape must are also present in the intestinal tract of vinegar flies. S. Afr. J. Enol. Vitic. 27: 46-50. Guzel-Seydim, Z. B., T. Kok-Tas, A. K. Greene and A. C. Seydim. 2011. Review: Functional properties of kefir. Crit. Rev. Food Sci Nutr. 51: 261-268. Hanukoglu, I. 1992. Steroidogenic enzymes: Structure, function and role in regulation of steroid hormone biosynthesis. J. Steroid Biochem. Mol. Biol. 43: 779-804. Hlivak, P., J. Odraska, M. Ferencik, L. Ebringer, E. Jahnova and Z. Mikes. 2005. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl. Lek. Listy. 106: 67-72. Hong, W. S., Y. P. Chen and M. J. Chen. 2010. The antiallergic effect of kefir lactobacilli. J. Food Sci. 75: H244-H253. Hosono, A. and Usman., 2000. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J. Dairy Sci. 83: 1705-1711. Huang, Y., X. Wang, J. Wang, F. Wu, Y. Sui, L. Yang and Z. Wang. 2013. Lactobacillus plantarum strains as potential probiotic cultures with cholesterol-lowering activity. J. Dairy Sci. 96: 2746-2753. Irvin, J. L., C. G. Johnson and J. Kopalo. 1944. A photometric method of the determination of cholates in bile and blood. J. Biol. Chem. 153: 439-457. Jones, M. L., H. Chen, W. Ouyang, T. Metz and S. Prakash. 2004. Microencapsulated genetically engineered Lactobacillus plantarum 80(pCBH1)for bile acid deconjugation and its implication in lowering cholesterol. Biomed. Res. Int. 2004: 61-69. Kakisu, E., A. G. Abraham, C. Tironi Farinati, C. Ibarra and G. L. De Antoni. 2013. Lactobacillus plantarum isolated from kefir protects vero cells from cytotoxicity by type-II shiga toxin from Escherichia coli O157:H7. J. Dairy Res. 1: 1-8. Kandler, O. and N. Weiss. 1986. Regular, nonsporing gram-positive rods. Bergey’s manual of systematic bacteriology. 2: 1208-1234. Kawase, M., H. Hashimoto, M. Hosoda, H. Morita and A. Hosono. 2000. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J. Dairy Sci. 83: 255-263. Kiessling, G., J. Schneider and G. Jahreisl. 2002. Original communication long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur. J. Clin. Nutr. 56: 843-849. Kimoto, H., S. Ohmomo and T. Okamoto. 2002. Cholesterol removal from media by lactococci. J. Dairy Sci. 85: 3182-3188. Kneifel, W. and H. Mayer. 1991. Vitamin profiles of kefirs made from milks of different species. Int. J. Food Sci. Tech. 26: 423-428. Kuo, C. Y. and C. W. Lin. 1999. Taiwanese kefir grains: Their growth, microbial and chemical composition of fermented milk. Aust. J. Dairy Technol. 54: 19-23. La Riviere, J., P. Kooiman and K. Schmidt. 1967. Kefiran, a novel polysaccharide produced in the kefir grain by Lactobacillus brevis. Arch. Microbiol. 59: 269-278. Leite, A., B. Mayo, C. Rachid, R. Peixoto, J. Silva, V. Paschoalin and S. Delgado. 2012. Assessment of the microbial diversity of Brazilian kefir grains by PCR-DGGE and pyrosequencing analysis. Food Microbiol. 31: 215-221. Li, T. and J. Y. L. Chiang. 2009. Regulation of bile acid and cholesterol metabolism by PPAR. PPAR research. 2009: 1-15. Lichtman, J. H., J. Amatruda, S. Yaari, S. Cheng, G. L. Smith, J. A. Mattera, S. A. Roumanis, Y. Wang, M. J. Radford and H. M. Krumholz. 2004. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. Am. Heart J. 147: 522-528. Lin, H. C., B. H. Su, A. C. Chen, T. W. Lin, C. H. Tsai, T. F. Yeh and W. Oh. 2005. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 115: 1-4. Lin, S. Y., J. W. Ayres, W. Winkler Jr and W. E. Sandine. 1989. Lactobacillus effects on cholesterol: In vitro and in vivo results. J. Dairy Sci. 72: 2885-2899. Liong, M. T. and N. P. Shah. 2005. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci. 88: 55-66. Liu, J. R., M. J. Chen and C. W. Lin. 2005. Antimutagenic and antioxidant properties of milk-kefir and soymilk-kefir. J. Agric. Food Chem. 53: 2467-2474. Liu, J. R., S. Y. Wang, M. J. Chen, P. Y. Yueh and C. W. Lin. 2006a. The anti‐allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J. Sci. Food Agr. 86: 2527-2533. Liu, J. R., S. Y. Wang, M. J. Chen, H. L. Chen, P. Y. Yueh and C. W. Lin. 2006b. Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters. Br. J. Nutr. 95: 939-946. Liutkevičius, A. and A. Šarkinas 2004. Studies on the growth conditions and composition of kefir grainas a food and forage biomass. Veterinarija Ir Zootechnika. T. ISSN 1392-2130. 25. Lye, H. S., G. R. Rahmat-Ali and M. T. Liong. 2010a. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int. Dairy J. 20: 169-175. Lye, H. S., G. Rusul and M. T. Liong. 2010b. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J. Dairy Sci. 93: 1383-1392. Madsen, M. B., A. M. Jensen and E. B. Schmidt. 2007. The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects. Clin. Nutr. 26: 792-798. Maeda, H., X. Zhu, K. Omura, S. Suzuki and S. Kitamura. 2004. Effects of an exopolysaccharide(kefiran)on lipids, blood pressure, blood glucose and constipation. Biofactors. 22: 197-200. Mann, G. V. and A. Spoerry. 1974. Studies of a surfactant and cholesteremia in the Maasai. Am. J. Clin. Nutr. 27: 464-469. Martensson, O., M. Biorklund, A. M. Lambo, M. Duenas-Chasco, A. Irastorza, O. Holst, E. Norin, G. Welling, R. Oste and G. Onning. 2005. Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans. Nutr Res 25: 429-442. Mathara, J. M., U. Schillinger, P. M. Kutima, S. K. Mbugua, C. Guigas, C. Franz and W. H. Holzapfel. 2008. Functional properties of Lactobacillus plantarum strains isolated from Maasai traditional fermented milk products in Kenya. Curr. Microbiol. 56: 315-321. Micheli, L., D. Uccelletti, C. Palleschi and V. Crescenzi. 1999. Isolation and characterisation of a ropy Lactobacillus strain producing the exopolysaccharide kefiran. Appl. Microbiol. Biotechnol. 53: 69-74. Miguel, M. G. d. C. P., P. G. Cardoso, L. d. A. Lago and R. F. Schwan. 2010. Diversity of bacteria present in milk kefir grains using culture-dependent and culture-independent methods. Food Res. Int. 43: 1523-1528. Moosmann, B. and C. Behl. 2004. Selenoprotein synthesis and side-effects of statins. Lancet. 363: 892-894. Nguyen, T. D. T., J. H. Kang and M. S. Lee. 2007. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int. J. Food Microbiol. 113: 358-361. Niedzielin, K., H. Kordecki and B. e. Birkenfeld. 2001. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol Hepatol. 13: 1143-1147. Ooi, L. G. and M. T. Liong. 2010. Cholesterol-lowering effects of probiotics and prebiotics: A review of in vivo and in vitro findings. Int. J. Mol. Sci. 11: 2499-2522. Otles, S. and O. e. Cagindi. 2003. Kefir: A probiotic dairy-composition, nutritional and therapeutic aspects. Pakistan J. of Nutr. 2: 54-59. Patterson, J. and K. Burkholder. 2003. Application of prebiotics and probiotics in poultry production. Poultry Sci. 82: 627-631. Rattray, D. D., C. M. O’Connell and T. F. Baskett. 2012. Acute disseminated intravascular coagulation in obstetrics: A tertiary centre population review(1980 to 2009). J. Obstet Gynaecol Can. 34: 341-347. Richelsen, B., K. Kristensen and S. Pedersen. 1996. Long-term(6 months)effect of a new fermented milk product on the level of plasma lipoproteins─a placebo-controlled and double blind study. Eur. J. Clin. Nutr. 50: 811. Rimada, P. S. and A. G. Abraham. 2001. Polysaccharide production by kefir grains during whey fermentation. J. Dairy Res. 68: 653-661. Schaafsma, G., W. Meuling, W. Van Dokkum and C. Bouley. 1998. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur. J. Clin. Nutr. 52: 436. Siezen, R. J. and J. E. van Hylckama Vlieg. 2011. Genomic diversity and versatility of Lactobacillus plantarum, a natural metabolic engineer. Microb. cell fac. 10: S3. Simons, L. A., S. G. Amansec and P. Conway. 2006. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr. Metab. Cardiovas. 16: 531-535. Smith, L. L. 1991. Another cholesterol hypothesis: Cholesterol as antioxidant. Free Radical. Bio. Med. 11: 47-61. Tamime, A., M. Wszolek, R. Božanić and B. Ozer. 2011. Popular ovine and caprine fermented milks. Small Ruminant Res. 101: 2-16. Tok, E. and B. Aslim. 2010. Cholesterol removal by some lactic acid bacteria that can be used as probiotic. Microbiol. Immunol. 54: 257-264. Uchida, M., I. Ishii, C. Inoue, Y. Akisato, K. Watanabe, S. Hosoyama, T. Toida, N. Ariyoshi and M. Kitada. 2010. Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet. J. Atheroscler. Thromb. 17: 980. Van Reenen, C. A. and L. M. Dicks. 1996. Evaluation of numerical analysis of random amplified polymorphic DNA(RAPD)-PCR as a method to differentiate Lactobacillus plantarum and Lactobacillus pentosus. Curr. Microbiol. 32: 183-187. Vlahcevic, Z., D. Heuman and P. Hylemon. 1996. Physiology and pathophysiology of enterohepatic circulation of bile acids. Hepatology: A textbook of liver disease. 1: 376-417. Wang, J., H. Zhang, X. Chen, Y. Chen and Q. Bao. 2012. Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet. J. Dairy Sci. 95: 1645-1654. Wang, S. Y., H. C. Chen, J. R. Liu, Y. C. Lin and M. J. Chen. 2008. Identification of yeasts and evaluation of their distribution in Taiwanese kefir and viili starters. J. Dairy Sci. 91: 3798-3805. Wang, Y., C. Li, P. Liu, Z. Ahmed, P. Xiao and X. Bai. 2010. Physical characterization of exopolysaccharide produced by Lactobacillus plantarum KF5 isolated from Tibet Kefir. Carbohydrate Polymers. 82: 895-903. Wang, Y., N. Xu, A. Xi, Z. Ahmed, B. Zhang and X. Bai. 2009. Effects of Lactobacillus plantarum MA2 isolated from Tibet Kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl. Microbiol. Biotechnol. 84: 341-347. Witthuhn, R. C., T. Schoeman and T. J. Britz. 2004. Isolation and characterization of the microbial population of different South African kefir grains. Int. J. Dairy Technol. 57: 33-37. Witthuhn, R., T. Schoeman and T. Britz. 2005. Characterisation of the microbial population at different stages of kefir production and kefir grain mass cultivation. Int. Dairy. J. 15: 383-389. Wolever, T., P. Spadafora and H. Eshuis. 1991. Interaction between colonic acetate and propionate in humans. Am. J. Clin. Nutr. 53: 681-687. Yadav, H. 2012. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. J. Diabetes Res. 2012. Zhang, F., X. Hang, X. Fan, G. Li and H. Yang. 2007. Selection and optimization procedure of synbiotic for cholesterol removal. Anaerobe. 13: 185-192. Zhang, M., X. Hang, X. Fan, D. Li and H. Yang. 2008. Characterization and selection of Lactobacillus strains for their effect on bile tolerance, taurocholate deconjugation and cholesterol removal. World J. Microb. Biot. 24: 7-14. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/60803 | - |
dc.description.abstract | 克弗爾是源自於高加索山的傳統發酵乳,為乳酸菌及酵母菌同質共生之克弗爾粒發酵而成,具有酸味、氣泡的口感及些許的酒精風味。先前研究證實,本實驗室之新竹組克弗爾,於餵食正常飼糧及高膽固醇飼糧之兩試驗組別中,皆具有降低倉鼠血液中總膽固醇、非高密度脂蛋白(non-high density lipoprotein)膽固醇及肝臟中總膽固醇之能力。故本研究由新竹組克弗爾粒中,篩選降膽固醇能力較佳之菌株,調查其可能之膽固醇移除機制,並且檢測其潛力益生菌之相關特性。
本研究由新竹組克弗爾粒中分離出38株乳酸菌,利用體外試驗檢測其膽固醇移除能力,加以篩選出具較高移除能力之菌株24、26及30,進一步利用16S rDNA定序進行鑑定。結果顯示,此三菌株皆為Lactobacillus plantarum。接下來檢測菌株於活細胞、休眠細胞(懸浮於0.85%氯化鈉溶液)及死細胞(高壓蒸氣滅菌)狀態之膽固醇移除能力,以瞭解其可能之膽固醇移除機制。結果顯示,三株菌於休眠細胞狀態皆具有移除能力,然於死細胞狀態僅有菌株26表現出高於20%之膽固醇移除能力。此研究指出菌株細胞壁直接吸附膽固醇,為可能移除機制之一。胞外多醣體(exopolysaccharide, EPS)與膽固醇移除能力具有關聯性,而菌株24、26及30之EPS產量分別為270、268及231 mg/L,三株菌之產量無顯著性差異。除此之外,考量到菌株開發為益生菌之可能,本研究同時測試菌株於腸道環境之耐受能力及貼附能力,結果顯示三菌株皆有高膽鹽耐受能力,而於酸處理環境下,菌數約降低1-2個對數值,然而此三菌株並未表現出良好的細胞貼附能力。 綜合上述,由克弗爾粒中所分離之Lb. plantarum 24、26及30具有膽固醇移除之機能性,為潛力益生菌株,而此三菌株之可能移除機制為物理性吸附及高產EPS之特性。 | zh_TW |
dc.description.abstract | Kefir is a traditional fermented milk which originated in the Caucasus Mountains. This beverage, fermented by kefir grains, a symbiotic culture of yeasts and lactic acid bacteria, has sour, carbonated and slightly alcoholic flavor. In our previous study, we found that Hsin-Chu kefir maintained in our laboratory could lower hamsters’ total cholesterol and non-high density lipoprotein (N-HDL) cholesterol level in serum on both cholesterol-free and cholesterol-enriched diets groups. Total cholesterol concentration in liver on different diets was significantly decreased in Hsin-Chu kefir group as well. In the present study, we further screened the strains from Hsin-Chu kefir grains with high cholesterol removing abilities. The possible cholesterol removing mechanisms and potential characteristics of probiotics were also investigated.
Thirty-eight lactic acid bacteria strains were isolated from Hsin-Chu kefir grain and evaluated their cholesterol removing abilities in vitro. Three strains, 24, 26 and 30, demonstrating the highest cholesterol removing rate, were selected. We further identified the selected strains using 16S rDNA sequencing. Three strains are all Lactobacillus plantarum. For investigating the possible mechanisms, we evaluated cholesterol removing ability of resting cells(suspended in 0.85% sodium chloride solution)and dead cells(autoclaved). Three strains in resting condition showed cholesterol removing ability, whereas, only strain 26 possessed 20% cholesterol removing ability in dead condition. The findings suggested that the cell wall binding might be one of mechanisms. Exopolysaccharide(EPS)also associated with reducing cholesterol. We then examined EPS producing abilities of the selected strains in MRS broth. The EPS levels of strains 24, 26 and 30 were 270, 268 and 231 mg/L, respectively. There are no significant differences among three strains. Additionally, for further application as probiotics, the tolerance in intestinal condition and adherence ability of the selected strains were also investigated. Results indicated the three strains possessed good bile salt tolerance. They also could survive under acid condition with about 1-2 log reduction. On the contrary, the strains didn’t demonstrated a good cell adherence ability. In conclusion, Lactobacillus plantarum strains 24, 26 and 30 isolated from kefir grains possessed cholesterol removing abilities. Physical binding and high EPS production might be the possible mechanisms associating with this functionality. This three strains can be potential probiotics strains. Key words: Cholesterol removing, Lactobacillus plantarum, Kefir grains, Probiotics | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T10:30:53Z (GMT). No. of bitstreams: 1 ntu-102-R99626011-1.pdf: 2420217 bytes, checksum: 1e2080c884a3848f97912b21c9a3d16e (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 壹、文獻探討 1
一、克弗爾 1 (一)克弗爾及其發酵菌元之組成 1 (二)微生物組成 2 (三)機能性 3 二、高膽固醇症 11 (一)膽固醇之生理機制 11 (二)高膽固醇症(hypercholesterolmia) 12 (三)克弗爾及益生菌株降膽固醇之潛力 13 (四)益生菌降膽固醇之機制 16 貳、材料與方法 23 第一節:以體外試驗篩選具降膽固醇特性之菌株 一、實驗材料 23 (一)克弗爾粒及菌株 23 (二)微生物培養基 23 二、實驗方法 23 (一)克弗爾粒菌株之分離、保存與活化 23 (二)膽固醇移除率 24 (三)菌株之鑑定 26 (四)菌株之碳源利用 29 第二節:降膽固醇菌株之機制探討 一、實驗材料 31 (一)實驗菌株 31 (二)微生物培養基 31 二、實驗方法 31 (一)活細胞、休眠細胞(resting cell)及死細胞之膽固醇移除能力 31 (二)疏水性(hydrophobicity)能力檢測 31 (三)胞外多醣體(exopolysaccharide, EPS)含量檢測 32 (四)掃描式電子顯微鏡觀察 33 (五)菌株之去連結(deconjugation)能力測定 34 第三節:潛力益生菌株之特性探討 一、實驗材料 35 (一)實驗菌株及細胞株 35 (二)微生物培養基 35 二、實驗方法 35 (一)菌株之酸及膽鹽耐受性能力檢測 35 (二)細胞之培養、計數及保存 36 (三)菌株貼附腸道細胞試驗 37 (四)膽固醇濃度對菌株生長速率之影響 38 (五)統計分析 38 參、結果與討論 39 第一節:以體外試驗篩選具降膽固醇特性之菌株 一、預備實驗─克弗爾粒已分離菌株之膽固醇移除能力檢測 39 二、檢測並篩選具膽固醇移除能力之菌株 41 三、菌株鑑定結果 45 第二節:降膽固醇菌株之機制探討 一、活細胞、休眠細胞及死細胞對膽固醇移除能力之影響 50 二、疏水性測試結果 53 三、胞外多醣體含量檢測 55 四、掃描式電子顯微鏡觀測結果 58 五、去膽酸連結能力 60 第三節:潛力益生菌株之特性探討 一、菌株貼附腸道細胞之特性 63 二、膽固醇濃度對菌株生長速率之影響 65 肆、結論 67 參考文獻 68 | |
dc.language.iso | zh-TW | |
dc.title | 從克弗爾粒中篩選具降膽固醇能力之潛力益生菌株並探討其可能之機制 | zh_TW |
dc.title | Selection of potential probiotic strains with cholesterol lowering ability from kefir grains and investigation of their possible mechanisms | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 劉?睿,林慶文,陳小玲,黃英豪 | |
dc.subject.keyword | 膽固醇移除,胚芽乳酸桿菌,克弗爾粒,益生菌, | zh_TW |
dc.subject.keyword | Cholesterol removing,Lactobacillus plantarum,Kefir grains,Probiotics, | en |
dc.relation.page | 77 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-08-15 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 2.36 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。